Menu

Home / For Visitors / 2024 Exhibitor Product / AI Multi-Cancer Early Detection Screening

AI Multi-Cancer Early Detection Screening

Category: Precision Medicine

Exhibitor: MARKER EXPLORATION CORP.

Booth No: M636

Characteristic

Marker X is a startup focused on developing biochemical and proteomic detection technologies, specializing in novel biomarkers and clinical applications. Using high-resolution mass spectrometry and a proprietary multi-indicator algorithm, we enable early cancer screenings for lung, colorectal, breast, and esophageal cancers, achieving detection rates exceeding 90% with only a small blood sample. Our mission is to help detect diseases early so that people can receive critical treatments sooner.

Products you may be interested in

Highest Rated Products

TOP